comparemela.com

Latest Breaking News On - University college dublin school - Page 1 : comparemela.com

Colchicine a New Tool for Stroke, CVD Event Recurrence?

The CONVINCE trial of the anti-inflammatory drug colchicine missed its primary endpoint, but secondary analyses suggested benefit.

The Kylemore Benedictines long road to a monastery

The Kylemore Benedictines long road to a monastery
ncronline.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncronline.org Daily Mail and Mail on Sunday newspapers.

BILLIONS still expected to die in coming years from COVID vaccines, says analyst – NaturalNews com

BILLIONS still expected to die in coming years from COVID vaccines, says analyst – NaturalNews com
naturalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naturalnews.com Daily Mail and Mail on Sunday newspapers.

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke and cardiovascular events in patients with non-cardioembolic stroke in the primary intention-to-treat analysis.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.